Search Jim Cramer's Mad Money trading recommendations using ourexclusive Mad Money Stock Screener and watch
NEW YORK ( TheStreet) -- "This rally today was based on nothing, or at least nothing that was good," Jim Cramer told the viewers of his "Mad Money" TV show Tuesday. He said simply that nobody trusts this market, and that makes rallies like today all the more painful. Cramer said he's baffled by today's market action, especially given that all the news of the day was bad. He said that everything from employment to home building, financial regulation to the oil stocks was going against the markets today, but it rallied anyway. "This is what I call a bad rally," said Cramer, "it's a rally caused by nothing more than shorts being out of position." Cramer characterized it as a rotating short squeeze, where short sellers are getting caught off guard amidst the market volatility and are forced to cover their positions. A rally like that, he concluded, can end on a dime. Cramer went further to explain that after the "flash crash" in May, where the Dow sank 1,000 points, the character of the market changed. He said that the markets now seem downright ridiculous, trading on the news of the day, or sometimes no news at all, rather than on the fundamentals or long-term trends. Cramer said that Washington is only making things worse, as it's focused on one thing and it's not jobs. He said that Washington's mantra is "punishment," punishment for healthcare, punishment for the banks, punishment for credit card companies, and now punishment for big oil. About the only stocks that make sense in this market are the ones Cramer's been preaching about, high-dividend payers and those with high growth. Other than those stocks, it's anyone's guess.
Merger BenefitsIn the "Executive Decision" segment, Cramer spoke with Glen Tullman, CEO of Allscripts-Misys Healthcare Solutions ( MDRX), a stock which has been under pressure since announcing a merger with Eclipsis, a leader in computerized hospital records. Tullman explained that as part of the deal Allscripts' other partner, Misys, is reducing its stake in the company from 55% to just 10%. He said the resulting deal will be a bigger, and better, Allscripts with even more profitability. When pressed further on why Misys is selling its stake in the company, Tullman explained that Misys took the opportunity to return value to its shareholders and help prop up its European banking business, which is in need of cash. Tullman said that Allscripts with Ellipsis will see long term appreciation and $40 to $45 million of extra free cash flow per quarter as part of the deal. He said the company will also see $40 million a year in cost savings from synergies. Tullman explained that Ellipsis brings computerized records to hospitals, which is a perfect fit for Allscripts, which mainly sells to physicians. Cramer agreed, saying that the combined company is a healthcare records powerhouse, one that's a lot more powerful than the current company. He remained bullish on the stock.
Sweet PortfolioIn the "Off The Charts" segment, Cramer went head to head with colleague Tim Collins over the charts of Cramer's high growth portfolio, first featured on June 3. The portfolio, which goes by the acronym C.A.N.D.I.E.S., includes Chipotle Mexican Grill ( CMG), Apple ( AAPL), Netflix ( NFLX), Deckers ( DECK), Intuitive Surgical ( ISRG), Express Scripts ( ESRX) and Salesforce.com ( CRM). Cramer owns shares of Apple for his charitable trust, Action Alerts PLUS. According to Collins, plotting these seven stocks against a chart of the S&P 500 shows the portfolio as having a strong, unbroken uptrend ever since the beginning of the year. He noted that a daily chart of these stocks' momentum shows that every time momentum dips to the 34-day moving average, its a great time to buy, a trend confirmed by the weekly chart as well. Even when looking at the relative strength index, Collins said Cramer's C.A.N.D.I.E.S. are looking sweet. He even went as far to suggest that the market seems to depend on these stocks surging higher. Cramer said Collins' technical analysis only proves what he deduced from the fundamentals: These seven stocks have pure, raw power.